With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
UAE expresses solidarity with Algeria, conveys condolences over victims of wildfires
UAE President hails Emirati women as 'pride of nation'
H.H. Sheikh Mohammed pays special tribute to mother on Emirati Women's Day
UAE leaders offer condolences following death of King of Norway
Emirati women are shaping UAE's stories: Sheikha Latifa
